{"version":"1.0","type":"link","title":"A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinoma.","author_name":"Hu M 외","author_url":"https://prs-insight.online/author/Hu%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/170141","thumbnail_width":1200,"thumbnail_height":630}